RecruitingNCT07013344
Association of Plasma N-terminal Pro-Brain Natriuretic Peptide Levels With the Burden of Coronary Artery Disease
Association of Plasma N-terminal Pro-Brain Natriuretic Peptide Levels With the Burden of Coronary Artery Disease: Insights From a Real-World Cohort
Sponsor
IRCCS Ospedale San Raffaele
Enrollment
800 participants
Start Date
Sep 1, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
This study aim to investigate the association between plasma NT-proBNP levels and the presence, extent and severity of stenosis in patients with suspected coronary artery disease.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- patient referred for elective coronary angiography due to suspected CAD.
- NT-proBNP measurement during hospitalization
Exclusion Criteria6
- heart failure
- severe valvular disease
- atrial fibrillation
- severe chronic kidney disease (eGFR \< 30 mL/min)
- prior coronary artery bypass grafting
- age over 80 years
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTBNP
Measurement of plasma NT-proBNP level.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07013344
Related Trials
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
NCT0695952441 locations
FORWARD CAD IDE Study
NCT0666250034 locations
Super High-pressure Balloon Versus Intravascular Lithotripsy to Prepare Severely Calcified Coronary Lesions
NCT070937883 locations
Safety and Effectiveness of the Crystalline Sirolimus-Eluting Device in Patients With Coronary Artery Disease
NCT074449571 location
Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention (PROMOTE)
NCT069165201 location